Cardinal Health Inc (CAH): EBITDA
$3.57B
Year ended 2026-06-30
+35.2%
3-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $3.57B | +16.4% | 2026-08-11, From 2025-07-01 |
| 2025-06-30 | $3.06B | +56.9% | 2026-08-11, From 2024-07-01 |
| 2024-06-30 | $1.95B | +35.2% | 2026-08-11, From 2023-07-01 |
| 2023-06-30 | $1.44B | n/m | 2025-08-12, From 2022-07-01 |
| 2022-06-30 | $85.00M | n/c | 2024-08-14, From 2021-07-01 |
| 2021-06-30 | $1.25B | n/m | 2023-08-15, From 2020-07-01 |
| 2020-06-30 | -$3.19B | n/m | 2022-08-11, From 2019-07-01 |
| 2019-06-30 | $3.06B | +164.2% | 2021-08-16, From 2018-07-01 |
| 2018-06-30 | $1.16B | -59.2% | 2020-08-13, From 2017-07-01 |
| 2017-06-30 | $2.84B | -8.5% | 2019-08-20, From 2016-07-01 |
| 2016-06-30 | $3.10B | +18.7% | 2018-08-22, From 2015-07-01 |
| 2015-06-30 | $2.61B | +11.4% | 2017-08-10, From 2014-07-01 |
| 2014-06-30 | $2.34B | +68.3% | 2016-08-12, From 2013-07-01 |
| 2013-06-30 | $1.39B | -34.2% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $2.12B | +15.9% | 2014-08-13, From 2011-07-01 |
| 2011-06-30 | $1.83B | +17.0% | 2013-08-20, From 2010-07-01 |
| 2010-06-30 | $1.56B | +3.2% | 2012-08-22, From 2009-07-01 |
| 2009-06-30 | $1.51B | -6.2% | 2011-08-26, From 2008-07-01 |
| 2008-06-30 | $1.61B | n/a | 2010-09-02, From 2007-07-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cardinal Health Inc (CAH) | 2026-06-30 | $3.57B | +16.4% |
| Cencora, Inc. (COR) | 2025-09-30 | $3.68B | +12.6% |
| McKesson Corp (MCK) | 2026-03-31 | $6.94B | +37.2% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $602.20M | +18.7% |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $118.02M | n/m |
| Cosmos Health Inc. (COSM) | 2025-12-31 | -$15.33M | n/m |
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | -$90.54M | n/m |
| Stemtech Corp (STEK) | 2025-12-31 | -$2.54M | n/m |
Compare CAH, COR, MCK, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗